PBM

Propel Bio Management Portfolio holdings

AUM $117M
1-Year Est. Return 64.07%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+64.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$172M
AUM Growth
+$51.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1
+$33.7M
2
+$10.9M
3
+$5.47M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$3.63M
5
APLT
Applied Therapeutics
APLT
+$3.31M

Top Sells

1
+$21.9M
2
+$5.87M
3
+$2.13M
4
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
+$2.13M
5
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$1.36M

Sector Composition

1 Healthcare 78.83%
2 Technology 1.46%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$351K 0.2%
22,368
27
– –
-5,792
28
– –
-27,712
29
– –
-165,000
30
– –
-9,267
31
– –
-104,195
32
– –
-1,372,360
33
– –
-12,148
34
– –
-45,695
35
– –
-85,442
1
2